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Abstract
Tumours evolve to cope with environmental stresses or challenges such as nutrient starvation, depletion of survival
factors, and unbalanced mechanical forces. The uncontrolled growth and aberrant deregulation of core cell homeo-
static pathways induced by genetic mutations create an environment of stress. Here, we explore how the adaptations
of tumours to the changing environment can drive changes in the motility machinery of cells, affecting migration,
invasion, and metastasis. Tumour cells can invade individually or collectively, or they can be extruded out of the sur-
rounding epithelium. These mechanisms are thought to be modifications of normal processes occurring during devel-
opment or tissue repair. Therefore, tumours may activate these pathways in response to environmental stresses,
enabling them to survive in hostile environments and spread to distant sites.
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Introduction
Metastasis remains a mysterious and untreatable fea-
ture of many cancers. If a primary tumour is detected
at early stage, it can often be removed by surgery and
the patient will have a high possibility of survival.
However, failed early detection of the primary tumour
can result in cancer metastasis, which is responsible
for more than 90% of cancer-related deaths. This is pri-
marily because of the complicated nature of tumour
dissemination and its resistance to various therapies
[1]. It is not well understood how tumours acquire
the ability to metastasise to distant sites. Here, we
explore the idea that a driver of metastasis may be pro-
vided by the hostile microenvironment triggering stress
responses that lead to hypervariability of normal pro-
grammes regulating cell migration, nutrient uptake,
and tissue organisation.
Evolution of tumours can be compared with evolu-
tion of organisms, as selection takes place in tumours
and more successful mutations are preserved over time,
similar to Darwin’s notion of ‘survival of the fittest’.
An interesting idea was put forth by Kirschner and
Gerhart in their book The Plausibility of Life [2], pro-
posing that each system in a cell or an organism has
evolved to contain built-in modules of variability,
which can be activated under stress or in the face of
new opportunities. This variability could confer sur-
vival advantages and allow relatively large programme
changes to occur in a flexible way under stress. If we
think of a tumour not as a randomly changing ball of
cells, but rather as an emerging system undergoing
selection to survive in our bodies by hijacking and
combining our intrinsic variability programmes, we
can think differently about what lies behind complex
phenomena such as metastasis of cancer. Multiple cell
processes could be subject to this selection and hyper-
variability activation under stress, but here we focus on
tissue organisation, cell migration, and nutrient uptake
via macropinocytosis, which uses the cell migration
machinery.
Cell migration is a fundamental process in multicellu-
lar organisms and is characterised by a coordinated
movement of individual or multiple cells in a specific
direction and location. Embryo formation, wound heal-
ing, and immune system function require cell migration
in multicellular organisms, highlighting its fundamental
importance for life. Pathways driving migration can be
turned on/off depending on the circumstances, but adult
epithelia, from which many solid tumours or carcinomas
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arise, show limited migration and tend to remain
attached to neighbouring cells in an organised way.
Metastasis is a complex multi-step process whereby
cancer cells gain motility to cross biological barriers
and colonise distant sites. This process initiates with can-
cer cells escaping the primary tumour site, sometimes
directly through tumour blood vessel vascular basement
membranes or alternatively through epithelial basement
membranes and extracellular matrix (ECM) to home to
and enter blood vessels through a process called intrava-
sation (Figure 1A). Cells can also enter the lymph sys-
tem and be carried to a distant organ or migrate along
tissue highways such as lymph vessels, nerves, and inter-
stitial spaces, where they will eventually reach a new site
(Figure 1A). Although only a few cells might survive in
the foreign environment, they may form micrometas-
tases, which can lie dormant or be suppressed by the host
immune system until they later grow into metastases [5].
From epithelia to single cells – actin drives
individual migration
Epithelia are composed of sheets and tubes of cells with
apical and basal polarity and have both a specific identity
and a niche where they reside relative to other cells and
the extracellular matrix. The regulation of epithelial
homeostasis has been extensively described in the litera-
ture (reviewed in [6,7]). Epithelial cells in adult tissues
were thought to be largely static, but are now known to
migrate during turnover in the normal intestine [8] and
in wound repair. Oncogenes and tumour suppressors
can initiate transformation of epithelial cells and cause
them to deviate from their normal programmes within
the tissue. Following transformation, epithelial cells
gradually lose characteristics of their epithelial identity
and gain the ability to access distant sites in the body
by migrating away from their neighbours and their
niche.
Cells can escape tumours either as single entities or as
collectives (Figure 1). Single cells generate protrusions,
modulate their adhesion, and use their actomyosin cyto-
skeleton to generate forces and propel through barriers
and across the ECM (Figure 1B). Typically, cells estab-
lish a front–rear polarity by positive and negative feed-
back mechanisms that create dominant centres of actin
assembly, adhesion or contractile force generation. The
Rho GTPase family of proteins plays key roles in regu-
lating single cell migration by orchestrating activation
and dynamics of multiple actin cytoskeletal regulating
proteins. While the networks of regulation are complex,
it is typically thought that Rac1 mainly regulates actin-
based protrusions; RhoA primarily mediates actomyosin
contractility; and Cdc42 coordinates polarity of adhe-
sion, contractility, and cell protrusion (reviewed in [9]).
Individual cell migration is controlled by the Rho
GTPase Rac1 interacting with the Scar/WAVE complex,
resulting in Arp2/3 activation and explosive nucleation
of branched actin filaments (reviewed in [10]). As a
result of multi-valent binding interactions, centres of
actin nucleation cluster together with receptors and asso-
ciated signalling scaffold proteins and form domains
resembling phase separations [11,12]. These clusters
allow sustained regional actin polymerisation and may
trigger crosstalk with other signalling molecules, which
enables cells to push the plasma membrane outward,
forming protrusions such as lamellipodia, filopodia,
and invadopodia. Lamellipodia are sheet-like protru-
sions containing dendritic branched actin networks
formed by the activity of Rac1 and Scar/WAVE. Rac1
binds directly to two different sites on the Scar/WAVE
complex, which may have distinct roles during activa-
tion and function of the complex as well as being
involved in complex multimerisation [13,14]. In addi-
tion, we have recently described a new negative regula-
tor of the Scar/WAVE complex, CYRI. CYRI can
compete with the Scar/WAVE complex for binding to
active Rac1 [15,16], but rather than preventing activa-
tion of Scar/WAVE, CYRI raised the threshold of
Rac1 activation at which the cell is capable of making
a burst of actin assembly. Actin-based lamellipodia are
also key structures used in uptake of extracellular parti-
cles such as pathogens. Loss of CYRI led to an increase
in uptake of salmonella in mice, implicating Rac1 and
CYRI in actin-mediated engulfment [17]. CYRI thus
likely raises the threshold at which activation of Rac1
leads to actin assembly by the Scar/WAVE complex to
assemble multiple types of actin structure, including
phagocytic cups for pathogen uptake.
As a driver of motility and cell cycle progression, the
Rac1–Scar/WAVE pathway is linked to cancer progres-
sion and metastasis in many tumour types. CYRI-B is
overexpressed in many cancers, but the significance of
this, if any, is unknown (Figure 2A). CYRI-B lies near
the gene encoding c-Myc on human chromosome
8 region q22 (Figure 2B), so it may be a passenger
amplification along withMYC in cancer. Rac1 is overex-
pressed either by gene amplification or by mRNA upre-
gulation (Figure 2C), usually correlating with poor
patient survival (Figure 2D). In melanoma, Rac1 is fre-
quently mutated at proline 29 (P29S), which raises its
activation levels by increasing the GDP/GTP nucleotide
exchange rates [20,21]. This point mutation promotes
actin assembly and lamellipodia formation and it was
also shown to increase proliferation independently of
the ERK/MAPK pathway in response to growth factor
deprivation [22]. Additionally, Rac1 P29S can drive a
mesenchymal transcriptional switch via serum response
factor [23]. This is clinically interesting, as BRAF kinase
is one of the most frequently mutated oncogenes in mel-
anoma and this mesenchymal switch promotes both
tumourigenesis and resistance to BRAF kinase inhibi-
tors [24]. TCGA data from 366 patients show that 6%
have mutated Rac1, with a significant effect on disease/
progression-free survival (Figure 2C). Melanoma
patients with Rac1P29S somatic mutation are resistant to
RAF inhibitors such as vemurafenib and dabrafenib,
whereas silencing of Rac1 in these cells reversed this
resistant phenotype [24]. Thus, this mutation may be
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selected during chemotherapy treatment, contributing to
cancer resistance and relapse. A new meta-analysis of
14 different studies with a total of 1793 cancer patients
found that high levels of Rac1 in different cancer types
including prostate, breast, hepatocellular, and non-
small-cell lung cancer were linked to tumour
malignancy, indicating that Rac1 overexpression may
be a potential biomarker for cancer progression [25].
Cells have multiple machineries that contribute to
migration and these act together depending on the peri-
cellular microenvironment. In the absence of protrusions,
e.g. by deletion of the Scar/WAVE or Arp2/3 complexes,
Figure 1. Cell migration and metastasis. (A) Illustration of the process of metastasis from a primary tumour site towards a secondary site, here
shown as the liver. Cancer cells have the ability to acquire a motile phenotype and migrate (either in clusters or as individuals). Fibroblasts can
assist the migration and invasive process and even serve as leader cells in the invasion [3,4]. Tumour cells invade through basement mem-
branes and extracellular matrix and enter the bloodstream via intravasation. The cancer cells can travel through the bloodstream and extrav-
asate at a secondary site where they will form new tumours (metastasis). Representative haematoxylin and eosin (H&E)-stained sections
taken from mouse Pdx1::Cre; KrasG12D; P53R172H pancreatic tumour and liver tissue with metastasis. Scale bars: 100 μm. (B, C) Two examples
of cell migration [single cell (B) and collective (C)] which will allow cancer cells to invade and metastasise to a distant site through either the
bloodstream or lymph system, or by invading through the extracellular matrix to a nearby organ.
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cells can still polarise and move, albeit much less effi-
ciently [26,27]. Additionally, protrusive forces are not
effective in conditions of very low adhesion or in extreme
confinement [28]. The contractile machinery of cells can
drive motility in most of these cases, sometimes acting as
a piston to generate force against the walls of the confined
space or to squeeze through tight spaces [29]. Contractile
activity is largely coordinated by RhoA, which regulates
the activity of the majormyosin activating pathways such
as Rho-kinase and myosin light chain kinase, as well as
inhibiting the myosin inactivating phosphatase. Rho-
mediated contractility is a major driver of tumour matrix
remodelling and motility of cancer cells [30,31].
In addition to protrusion and contractile squeezing,
adhesion forces have a strong effect on how cells migrate
and whether they can efficiently move in different envi-
ronments. Adhesion and its role in migration have been
well studied and some informative reviews can be found
[32–36]. To summarise briefly, new adhesions form in
the leading edge of lamellipodia when cells migrate
across a rigid substrate. Nascent adhesions mature as
actin assembles and flows retrogradely towards the cell
Figure 2. CYRI-B and Rac1 can be altered in different types of cancer. (A) The alteration frequency of CYRI-B in different types of cancer.
(B) The CYRI-B gene is located near MYC on chromosome 8q 22. From NCBI Human Genome resource https://www.ncbi.nlm.nih.gov/
genome/guide/human/. (C) Alteration frequency of Rac1 in different types of cancer. (C) Kaplan–Meier survival curve of patients with or with-
out Rac1P29S somatic mutation. Data obtained from cBioPortal for Cancer genomics database [18,19].
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body and is bundled into stress fibres and actin cables.
Many focal adhesion proteins are tension-sensitive and
respond to increased force [36]. In softer environments
and in 3D matrix, the process is similar, but focal adhe-
sions tend to be smaller and form in regions where the
cell contacts matrix fibres [37]. As focal adhesions have
differing compositions and sub-types, there is still a lot
to learn about how they respond to force and the role
of individual protein components in signalling and
mechanics.
Actin not only drives protrusion at the plasma mem-
brane but also plays a key role in sculpting membranes
that drive endocytic uptake, trafficking, and recycling.
Recycling of receptors such as integrins and receptor
tyrosine kinases (RTKs) regulates adhesion to the
ECM as well as actin organisation for migration towards
nutrient gradients [38]. The Scar homologue and Arp2/3
complex activator, WASH, complex facilitates the recy-
cling of specific proteins from the plasma membrane to
the leading edge of invading cells [38]. This mechanism
is essential in recycling of proteins involved in invasion
and metastasis, including various integrins, membrane
spanning metalloproteases such as MT1-MMP, and
RTKs such as EGFR [39,40]. A recent study also
showed that upregulation of proteins involved in recy-
cling such as clathrin light chain b (CLCb) and
dynamin-1 (Dyn1) can be correlated with poor prognosis
in patients with non-small-cell lung cancer [41]. These
two proteins regulate the recycling of EGFR through
clathrin-mediated endocytosis, and upregulation of both
CLCb and Dyn1 can enhance EGFR recycling to plasma
membrane, leading to increased invasion and metastasis
in vivo [41]. Thus, individual cell migration is driven by
coordination of protrusion, contractile function, adhe-
sion, and trafficking. All of these processes depend on
actin dynamics and are controlled by signals from mem-
brane receptors and contact with the matrix.
Collective cell migration
During embryogenesis, tissue and tube formation is
achieved through collective cell migration. Collective
cell migration also occurs in the adult intestine, a tissue
that turns over rapidly and proliferates mostly near the
base of the finger-like villi in structures called crypts. It
has long been the subject of debate whether intestinal
epithelial cells actively migrate using protrusions or are
just passively pushed along as they crowd due to prolif-
eration. New evidence shows that intestinal epithelial
cells in mice use active migration, with Arp2/3 and
actin-based protrusions against the basement membrane
[8]. This is a nice example of collective migration occur-
ring in normal adult tissue as a part of regeneration.
Many types of tumours also display prominent collective
invasion. Histological 3D reconstruction of several
tumour types revealed that most invasion near a tumour
is collective and often finger-like [42]. This type of inva-
sion is also linked to poor prognosis [43,44]. Whether
collective migration of tumour cells results from a
wound-healing response, an aberrant developmental
programme, or some combination remains to be
understood.
When cells migrate as a collective, they display simi-
lar molecular mechanisms to single cell migration, such
as protrusion, adhesion, and contractile forces, but they
also require coordination of cell–cell adhesion or repul-
sion. Individual cells dynamically alter their actin cyto-
skeleton to establish a front–rear polarity axis.
Conversely, during collective cell migration, the cluster
of cells will establish a polarised axis across several cell
lengths, by having leader cells at the front and follower
cells at the back (Figure 1C). The two types of cells pre-
sent in the cluster exhibit differences in signalling, gene
expression, and morphology. Indeed, leader cells have a
more migratory and protrusive phenotype and thus are
thought to direct orientation of movement and the speed
of the cluster in response to environmental stimuli [45].
For collective cell migration to be successful, suffi-
cient coordination of cell–cell and cell–matrix interac-
tions is required. Therefore, understanding the role of
leader/follower cells within an adherent group during
collective migration is critical. Studies from model
organisms such as fish, flies, and mammals suggest that
cells at the edges of a cluster sense microenvironmental
cues, allowing them to become leader cells [46–48].
Alternatively, clusters may contain cells predisposed to
become leader cells, which migrate towards the front,
where they orchestrate and direct collective migration
[49,50]. A third possibility is that a different type of cell,
such as a fibroblast, could take over as a leader of collec-
tive migration – which can lead to cancer invasion
(Figure 1C and [3,4]). A new study using a 3Dmicroflui-
dic device that enables real-time imaging of mammalian
cell clusters during migration characterised the dynam-
ics of leader and follower cells and found that pre-
existing keratin 14 (K14)-positive cells in a tumour orga-
noid have the potential to become leader cells. These
cells can polarise and migrate as leaders, due to environ-
mental stimuli from the tumour microenvironment as
well as chemokine gradients, which are sensed by the
fibrillar collagen receptor DDR2 and the DF1 chemo-
kine receptor CXCR4, respectively [51].
Leader and follower cells have different roles in col-
lective migration during normal embryonic development
events, such as in angiogenic sprouting or neural crest
migration. Single-cell RNA sequencing of invading neu-
ral crest collectives revealed that leader cells have upre-
gulation of genes essential in signalling and motility.
Examples include Rho-GTPases, actin cytoskeletal
genes and Wnt/PCP (planar cell polarity) genes [52].
However, even within the neural crest, the trunk versus
cranial neural crest cells use different mechanisms for
collective migration; cranial migration of chick and zeb-
rafish showed no continuous presence of a leader,
whereas trunk migration showed an established leader
directing the follower cells [53]. The Wnt/PCP pathway
establishes proper polarisation of cells through an asym-
metric distribution of members of this pathway in an
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individual cell by antagonising other protein complexes
intracellularly [54,55]. This asymmetry can then be dis-
tributed to the adjacent cells through intercellular
protein–protein interactions and therefore generate a
local polarity within the cluster enabling a proper coordi-
nated migration [55,56]. Wnt/PCP pathways are fre-
quently hijacked in cancers and lead to aberrant tissue
organisation, inappropriate identity, and stemness fea-
tures [55,56].
Recently, the importance of energy regulation was
highlighted for collective migration and leader/follower
status of cells. Leader cells can become follower cells
in response to energy depletion during invasive migra-
tion, an energy-demanding process [57]. During inva-
sion through matrix barriers, breast cancer cells were
found to take up higher levels of glucose, leading to
increased energy production. The ATP/ADP ratio of
the leader cells was increased in the instant before a
major contraction during leader cell invasion. However,
mathematical modelling revealed that when this energy
drops below a threshold, the leader cells can become fol-
lowers and a more energetic follower cell will lead until
the first leader cell regains its energy. This swapping pro-
moted efficient collective invasion of a cell cluster,
whereas delays in this switch between leader/follower
cells can disrupt the invasion process [57].
Pressures driving migration: chemotaxis and self-
generated gradients
Migration of single cells or clusters can be driven and
spatially directed by a variety of extracellular chemical
cues, a process known as chemotaxis (Figure 3). While
chemotaxis towards sources of attractant has been exten-
sively reported and characterised, an emerging concept
is that cells can often generate their own chemoattractant
gradient by consuming or destroying local supplies. A
dramatic example was the discovery that melanoma cells
chemotax towards lysophosphatidic acid (LPA), a driver
of cancer cell intravasation and metastasis [58]. Specifi-
cally, primary tumours can rapidly consume LPA, acting
as ‘sinks’, eventually motivating cells to migrate out in
response to self-generated gradients [58]. This mecha-
nism also works in pancreatic cancer, with LPA promot-
ing metastasis through a signalling loop with the actin
modulating protein N-WASP [59]. The LPA receptor,
LPAR1, which is thought to drive this chemotactic
response, is a G-protein-coupled 7-transmembrane span-
ning receptor and its endocytic trafficking is directed by
N-WASP [58,59]. Multiple chemokines are also impli-
cated in cancer cell chemotaxis and this has recently
been reviewed in [60]. Likewise, growth factors such
as EGF, PDGF, and HGF are well characterised as stim-
ulators of chemotaxis and are all internalised together
with their receptors. Receptor tyrosine kinase signalling
is also important in chemotaxis, where Muinonen-
Martin et al found that growth factors modulate the
speed of translocation of cells in a chemotaxis chamber,
but only modestly affect directionality [58]. There is also
increasing evidence that extracellular vesicles could pro-
mote chemotaxis through growth factors and chemo-
kines. Exosomes displaying these cues are able to
direct migration (autocrine manner), whereas exosomes
that are left behind can be taken up by follower cells
enabling directed migration (paracrine manner)
[60,61]. Karagiannis et al recently reviewed certain
exciting efforts to translate our knowledge around che-
motaxis of breast cancer cells into signatures that can
be used to predict or intervene against metastasis [62].
It has emerged from the work of Oktay, Condeelis and
co-workers that haematogenous metastatic dissemina-
tion of breast (and other) cancers occurs through a col-
laboration between macrophages and tumour cells to
penetrate blood vessels in a phenomenon called TMEM
(tumour microenvironment of metastasis) [63]. It is clear
that more research into chemotactic drivers and self-
generated gradients will be important to maximally
understand how various mediators could be manipulated
to better combat tumour spread.
Pressures driving migration: starvation for
nutrients and macropinocytic uptake
Tumours not only consume/destroy attractants rapidly,
but they grow and expand faster than they can supply
nutrients or oxygen, due to uncontrolled proliferation
and poor vascularisation (Figure 3). Cancer cells readily
respond to the stress of starvation by ramping up nutrient
uptake pathways, utilising alternative sources of energy,
and rewiring their metabolism (reviewed in [64,65]).
The actin cytoskeleton is highly responsive to these con-
ditions and consequently is a major driving force of
nutrient uptake upon energy demand. Furthermore, the
starvation response in tumours is linked with cell migra-
tion reprogramming in ways that are strikingly con-
served in evolution [66]. The reprogramming of
migration pathways in tumours has been compared with
bacterial reprogramming during starvation and yeast
pseudohyphal growth induced upon starvation. It
involves rewiring of protein translation through the
eukaryotic translational initiation factor eIF2a, leading
not only to reduced global protein translation but also
to a switch of a more invasive and migratory programme
of translation and transcription via the ATF4 transcrip-
tion factor (recently reviewed in [66]). Here, we discuss
mainly the reprogramming of the cytoskeleton to effect
nutrient uptake by macropinocytosis, a method for
engulfment of large particles that can serve as a food
source.
Excessive activation of Ras or Rac GTPases (such as
due to oncogenic mutations) can drive actin cytoskeleton
remodelling causing plasma membrane ruffling and bulk
engulfment of extracellular material through a process
called macropinocytosis [67] (Figure 3). The cell forms
cup-like structures around particles, after which the
membranous distal tips fuse together forming a
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macropinosome. After engulfment, macropinosomes
fuse with lysosomes to break down and consume the
extracellular material, fuelling survival [68]. Macropino-
cytic cup formation is largely driven by Rac1–Scar/
WAVE and Arp2/3 [69,70]. However, many aspects of
how macropinosomes are formed are unknown. In the
early stages, actin organises into a protrusive ring under-
neath the plasma membrane as a precursor of a macropi-
nocytic cup. A study using super resolution lattice light-
sheet microscopy recently revealed how this ring accu-
mulates active Ras and Rac1 as well as PI3,4,5P3 mole-
cules, whereas at the edge of this cup Scar/WAVE is
activated. Actin polymerisation at the interface of this
nascent cup drives extracellular accumulation and cup
closure mediates uptake in gulps [71]. Abi, a protein
subunit of the Scar/WAVE complex, localises in macro-
pinocytic vesicles during synaptic development in Dro-
sophila melanogaster. Upon phosphorylation by Abl
kinase, Abi is thought to regulate Rac1 Scar/WAVE-
mediated actin assembly [72]. PI3K is also important
for macropinosome formation by converting PI4,5P2
into PI3,4,5P3, which somehow defines regions/bound-
aries of the macropinosome and enables membrane pro-
trusion extension. This mechanism can be
downregulated by the tumour suppressor phosphatase
PTEN, which will convert PI3,4,5P3 back to PI4,5P2
and inhibit the closure of macropinosomes [73].
Macropinocytosis of proteins can fuel pancreatic can-
cer when other nutrients are in short supply [74].
Tumours can break down proteins taken up from the
microenvironment by macropinocytosis [75,76]. A
recent study has shown that non-small-cell lung cancer
cells can survive glucose shortage by upregulating
Rac1-mediated macropinocytosis. Macropinocytosed
protein can be broken down and used to generate ATP
through the activation of the tricarboxylic acid (TCA)
cycle, fuelling proliferation [77]. PTEN is often inactive
or deleted in many cancer types, including prostate can-
cer, and PTEN-deficient prostate cancer cells can survive
under nutrient starvation by upregulatingmacropinocyto-
sis through AMPK pathway activation [78]. Rather than
taking up soluble proteins from the environment
(e.g. albumin), PTEN-deficient prostate cancer cells
engulf necrotic cell debris to power protein synthesis
and lipid maintenance, processes essential for tumour
growth [78]. Thus, macropinocytosis can provide
tumours with a variety of types of nutrients and may be
a process worth targeting in therapy.
Targeting macropinocytosis via the actin cytoskeleton
or its regulators could be considered a potential therapeu-
tic target. However, there are no specific inhibitors for
macropinocytosis. The Rac1 GEF, DOCK1, is a potential
therapeutic target for macropinocytosis in tumours with
Rac1P29S mutation, as its inhibition caused a decrease in
invasion and macropinocytosis of both melanoma and
breast cancer cells harbouring Rac1P29S mutations [79].
Moreover, a pharmacological screen recently identified
new potential therapeutic agents against macropinocyto-
sis. In this study, about 640 FDA-approved compounds
were screened using variousmolecular biology techniques
Figure 3. Pressures driving cell migration. Stresses and imbalances associated with the tumour environment can promote cell migration and
can lead to metastasis. Common drivers include imbalances in attractants due to consumption by the primary tumour, leading to chemotaxis;
nutrient starvation leading to migration and macropinocytic uptake; cell crowding and unbalanced mechanical forces, leading to extrusion,
invasion, and migration.
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and scanning electron microscopy. Imipramine, a tricyclic
antidepressant compound, with IC50 ≤ 131 nM, was found
to inhibit the initial steps of macropinocytic cup formation
in various cells including cancer cells [80]. Although this
compound could be promising, more studies need to be
performed to understand the mechanisms of its function
as a therapeutic agent in pathologies including cancer.
Pressures driving migration: cell crowding and
unbalanced mechanical forces
Epithelial tissue homeostasis is crucial for maintaining a
functional protective barrier and is established through
balancing forces between resting, dividing, and dying
cells. To allow turnover and prevent overcrowding of
cells in an epithelium, dying cells are extruded from
the monolayer (Figure 4). In zebrafish epithelium, cell
extrusion is achieved by contraction of an actomyosin
ring, leading to the excess cells being squeezed out api-
cally to maintain a functional epithelial monolayer
[81]. Cell extrusion is also a mechanism for elimination
of abnormal neighbouring cells, termed EDAC (epithe-
lial defence against cancer). Healthy epithelial cells have
the ability to detect cancerous neighbouring cells and
apically extrude them from the epithelial tissue
(reviewed in [82]). This process is also correlated with
actomyosin contractility, as Src-transformed cells that
were extruded by normal neighbouring cells showed
high levels of myosin-II [83]. Normal epithelial cells
can extrude surplus cells apically into the lumen; how-
ever, tumours also squeeze cancer cells basally,
promoting invasion in response to oncogenic signalling.
This aberrant extrusion can allow them to enter the
bloodstream and metastasise to distant sites [84]
(Figure 4). Extrusion of single cells from epithelia has
been highlighted as a way for single cells to disseminate
from tumours or even from precancerous sites [81,84].
Cancer driver mutations, such as KrasG12V or G12D,
can promote basal cell extrusion, explaining why
tumours harbouring such mutations, including pancre-
atic cancer, can be so invasive and metastatic. The mech-
anism of extrusion may be via lipid signalling through
sphingosine-1-phosphate (S1P), as the S1P2 receptor is
important in the extrusion of pancreatic ductal adenocar-
cinoma cells driven by the KrasG12V mutation. Deletion
of S1P2 receptor increased the basal extrusion and
increased the invasive properties of cancer cells, whereas
re-introduction of the protein reverted the phenotypes
and reduced metastasis [85,86]. Loss of E-cadherin in
mouse mammary epithelial cells can also lead to cell
extrusion, but it is not sufficient for formation of invasive
lobular carcinomas. The extruded E-cadherin-deficient
cells showed increased levels of phospho-myosin light
chain and non-apoptotic membrane blebbing. Reduction
of contractility resulted in increased survival and prolif-
eration, as well as the development of invasive lobular
carcinoma [87].
Physical pressures derived not only from neighbour-
ing cells but also from the surroundingmatrix can trigger
cell migration. The structural properties of the ECM and
the pericellular microenvironment can influence the
directional migration of cancer cells. Cells typically
migrate following gradients of increasing stiffness, a
substrate stiffness-mediated directed programme of
Figure 4. Cell extrusion in health and disease. In healthy tissue, cells can be extruded apically from the epithelial monolayer, due to over-
crowding, and undergo apoptosis. In tumours, cancer cells can be extruded (due to overcrowding, oncogenic signalling, and/or starvation)
either apically or basally towards the basement membrane and invade through the extracellular matrix to gain access to interstitial spaces
and distant organs.
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migration also known as durotaxis. Human cancer cells
can also durotax, and they prefer softer stiffness gradi-
ents (2–7 kPa), similar to normal soft tissue, whereas
upon a threshold of stiffness cells displayed a milder
response [88]. Inhibition of Arp2/3 complex impaired
lamellipodia protrusion and durotaxis [88]. In addition
to this, neuronal Schwann cells can also migrate direc-
tionally and change their phenotype in response to gradi-
ents of increasing extracellular stiffness, a response
essential for nerve regeneration [89].
Increasing evidence suggests that a migratory cell can
sense ECM stiffness through filopodia, finger-like pro-
trusions generated by actin polymerisation at the leading
edge. Filopodia have been implicated in durotactic
migration as well as ECM invasion. Filopodia not only
sense the rigidity of the environment but they can also
promote migration through generation of forces pro-
duced by combining actomyosin contractility and bind-
ing to ECM fibres [90,91]. Mathematical modelling
and experiments in embryonic chick forebrain neurons
suggested a stochastic model, the ‘motor-clutch’ force
transmission system, where the retrograde flow of F-
actin in filopodia was faster with less traction forces in
matrices with higher stiffness, and the clutch was more
engaged and the retrograde flow slower on softer sub-
strata [92]. An application for quantification of filopodia
microscopically was recently developed and used to
show that invading breast cancer cells use filopodia in
3D during invasion [93]. Filopodia are also important
for invasion of melanoma cells expressing the actin bun-
dling protein fascin-1 [94]. However, much still remains
unknown about the importance of filopodia in cancer cell
force production for matrix remodelling and invasion.
Numerous observations implicate ECM stiffness and
mechanical forces in tumour progression, invasion, and
metastasis. For example, in breast cancer, stiffening of
the ECM and the surrounding stromal tissue can activate
mechano-signalling pathways in cancer cells that will
lead to cell proliferation, changes in cell shape, and
migration [95]. Furthermore, epithelial ovarian cancer
cells show enhanced actomyosin contractility in
response to greater substrate rigidity [96]. This corre-
lated with increased cell spreading, alterations of focal
adhesion properties, and enhanced durotaxis [96].
Mechanoresponses may be transduced by focal adhesion
kinase (FAK), as it is one of the first proteins recruited to
focal adhesions in response to an external mechanical
stimulus. Upon increased stiffness, active FAK can
cause translocation of the transcriptional regulator Yes-
associated protein (YAP) to the nucleus, which can lead
to increased expression of genes essential for durotaxis,
directed migration, and metastatic spread [97].
The actin cytoskeleton can also drive metastatic
spread through generation of forces at the basement
membrane. It is widely known that basement membrane
breaching occurs in various processes and is important
during development as well as immune cell migration
and function [98]. Caenorhabditis elegans provides a
fascinating model for normal developmental breaching
of basement membrane and invasion during vulval
development. A single cell, called the anchor cell,
assembles invadopodia and uses both metalloproteases
and actin assembly to force its way through the basement
membrane. However, it was recently shown that deletion
of the genes encoding matrix metalloproteases failed to
stop this invasion event. Enhanced F-actin polymerisa-
tion at the protrusive invasive area and recruitment of
mitochondria to produce ATP locally at invading sites
were also required for anchor cell invasion [99]. Thus,
local energy production can fuel actin dynamics to gen-
erate force-producing invasive structures. Cancer-
associated fibroblasts (CAFs) also use mechanical forces
generated by actin cytoskeleton remodelling to breach
the basement membrane and invade through pre-existing
cavities and widen the holes, enabling them to squeeze
through and invade [100]. Thus, both normal and tumour
cells can respond to mechanical barriers by increasing
their own force production machinery to overcome bar-
riers and to disseminate.
Conclusion
Both normal and tumour cells have plastic mechanisms
to adapt their migration and invasion strategies accord-
ing to the various stresses and demands of the environ-
ment. Transcriptional regulation of migration
programmes is perhaps the best understood among
changes driving tumour migration, with a vast literature
surrounding the epithelial-to-mesenchymal transition.
While concepts surrounding epithelial-to-mesenchymal
transition have made great contributions to our under-
standing of cancer, we would argue that there is not
one programme driving migration changes in tumour
cells, but rather an opening up of possibilities due to
stress. The cytoskeleton has inbuilt flexibilities to allow
cells to cope with normal stresses. Essentially, the cyto-
skeleton is intimately linked to other cellular systems,
such as membrane trafficking, proliferation, energy
flow, and polarity. Cancer presents extreme stress to
cells and thus they harness flexibilities of normal cyto-
skeletal programmes which can lead to metastatic
spread. If we can better understand the range of
responses that cells can make in both normal and dis-
eased states, we can hope to find weaknesses in these
strategies and exploit them for better therapies.
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